Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Arthur Tzianabos, the chair of Stoke Therapeutics (STOK 2.52%), disclosed the direct sale of 4,355 shares of Common Stock for a transaction value of approximately $174,000 on March 10, 2026, according to a SEC Form 4 filing.Transaction summaryMetricValueShares sold (direct)4,355Transaction value~$174,000Post-transaction common shares (direct)31,339Post-transaction value (direct ownership)~$1.20 millionTransaction value based on SEC Form 4 weighted average purchase price ($40.00); post-transaction value base ...